Prevalence and predictors of HIV-associated weight loss in the era of highly active antiretroviral therapy

International Journal of STD and AIDS

Volumn 13, Issue 11, 2002, Pages 744-747

  Batterham, M J ^a   Garsia, R ^a   Greenop, P ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

AIDS; Dietary intake; HIV; Lipodystrophy; Weight loss

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; DIETARY INTAKE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; VIRUS LOAD; WEIGHT REDUCTION;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CROSS-SECTIONAL STUDIES; ENERGY INTAKE; FEMALE; HIV INFECTIONS; HIV WASTING SYNDROME; HUMANS; LIPODYSTROPHY; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PREVALENCE; VIRAL LOAD; WEIGHT LOSS;

EID: 0036841028     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646202320753682     Document Type: Article

References (27)

1. Coodley GO, Loveless MO, Merrill TM. The HIV wasting syndrome: A review. J Acquir Immune Defic Syndr 1994;7:681-94
2. Chlebowski RT, Grosvenor M, Bernhard N, Morales L, Bulcavage L. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol 1989;84:1288-93
3. Edwards P, Wodak A, Cooper DA, Thompson IL, Penny R. The gastrointestinal manifestations of AIDS. Aust NZ J Med 1990;20:141-8
4. Kotler DP, Tierney AR, Wang J, Pierson-RN Jr. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 1989;50:444-7
5. Melchior JC, Niyongabo T, Henzel D, et al. Malnutrition and wasting, immunodepression, and chronic inflammation as independent predictors of survival in HIV-infected patients. Nutrition 1999;15:865-9
6. Casari S, Donisi A, Paraninfo G, et al. Prognostic factors correlated with survival in AIDS patients. Eur J Epidemiol 1999;15:691-8
7. Rodolphe T, Denis M, Catherine M, Fraincois D. Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA). Eur J Epidemiol 2000;16:633-9
8. Grunfeld C, Pang M, Shimizu L, et al. Resting emergency expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992;55:455-60
9. Macallan DC, Noble C, Baldwin C, et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995;333:83-8
10. Carbonnel F, Maslo C, Beaugerie L, et al. Effect of indinavir on HIV-related wasting. AIDS 1998;12:1777-84
11. Silva M, Skolnik PR, Gorbach SL, et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998;12:1645-51
12. Wanke C, Silva M, Knox TA, et al. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 2000;31:803-5
13. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-58
14. Mann M, Piazza-Hep T, Koller E, Struble K, Murray J. Unusual distributions of body fat in AIDS patients: A review of adverse events reported to the food and drug administration. Aids Patient Care STDS 1999;13:287-95
15. Dong KL, Bausserman LL, Flynn MM, et al. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). J AIDS 1999;21:107-13
16. Miller KD, Jones E, Yanovski JA, et al. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998;351:871-5
17. Lo JC, Mulligan K, Tai VW, Algren H, Schambelan M. 'Buffalo hump' in men with HIV-1 infection. Lancet 1998; 351:867-70
18. Renard E, Fabre J, Paris F, Reynes J, Bringer J. A syndrome of body fat redistribution in HIV-1-infected patients: Relationships to cortisol and catecholamines. Clin Endocrinol 1999;51:223-30
19. Norton K, Wittingham N, Carter L, Kerr D, Gore C, Marfell- Jones M. Measurement techniques in anthropometry. In: Norton K, Olds T, eds. Anthropometrica. Marrickville, NSW, Australia: University of New South Wales Press, 1996: 25-75
20. Kotler DP, Burastero S, Wang J, Pierson-RN Jr. Prediction of body cell mass, fat-free mass, and total body water with bioelectrical impedance analysis: Effects of race, sex, and disease. Am J Clin Nutr 1996;64:489S-97S
21. Batterham MJ, Garsia R, Greenop P. Measurement of body composition in people with HIV/AIDS: A comparison of bioelectrical impedance and skinfold anthropometry with dual-energy X-ray absorptiometry. J Am Diet Assoc 1999;99: 1109-11
22. Matthews DR, Kosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19
23. Batterham M, McKay E, Brown D. Development of a food frequency questionnaire (FFQ) specifically for use in HIV/AIDS. Nutrition 1997;13:291 (Abstract)
24. Harris JA, Benedict FG. A Biometric Study of Basal Metabolism in Man. Publication no 279. Washington, DC: Carnegie Institute of Washington. 1919: 1-266
25. Graham NH, Munoz A, Bacellar H, et al. Clinical factors associated with weight loss related to infection with human immunodeficiency virus type 1 in the Multicenter AIDS Cohort Study. Am J Epidemiol 1993;137:439-46
26. Rivera S, Briggs W, Qian D, Sattler FR. Levels of HIV RNA are quantitatively related to prior weight loss in HIV-associated wasting. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:411-18
27. Lyles RH, Tang AM, Smit E, et al. Virologic, immunologic, and immune activation markers as predictors of HIV-associated weight loss prior to AIDS. AIDS 1999;22:394